EMR vs XYL
as of Friday's close
- EMRBuy morein five trading days−9.3%
Emerson Electric fell 9.3% over the past five trading days, in step with other industrial stocks (down 7.6%), but its sales grew 5.4% over the past year.
- XYLSell some2%
Xylem's report on Oct 27 missed profit forecasts by 2%, and its sales grew only 1.9% over the past year.
Percent return
- EMR+23.82%
- XYL−30.46%
Nov 20, 2025 to Nov 20, 2026
Where they differ
- Company size: EMR $91.3B, XYL $21.6B.
- Sales growth, 1 yr: EMR +5.4%, XYL +1.9%. EMR is ahead.
- Price for $1 of next year's profit: EMR $23, XYL $17. XYL is ahead.
- Profit per $1 of sales: EMR 21¢, XYL 16¢. EMR is ahead.
- Cash minus debt: EMR −$10.4B, XYL −$2.32B. XYL is ahead.
- Price change, 1 yr: EMR +24%, XYL −30%. EMR is ahead. S&P 500 +6.8%.
- How much the price swings: EMR 30%, XYL 39%. EMR is ahead.
EMR: our only Buy more, with faster sales growth
Our pick of these: Emerson Electric
Sales growth +5.4% vs +1.9%
EMR +5.4%, XYL +1.9%.Forward P/E per point of sales growth 4.24 vs no growth
EMR 4.24, XYL no growth.Keeps 21.1% of sales as operating profit, vs 15.5%
EMR 21.1%, XYL 15.5%.Where it loses: XYL has more analyst upside, +24.8% vs +21.0%
Cover this stock to see the full report
The call, its reasons and what would change it are free for everyone. The price zones, the whole brief and how the call has moved come with covering a stock. Use one of your three covered slots, or go Pro for every stock.
Prices as of Friday, 3:59 PM ET. A view, not advice.